MAPT and Atrophy: Second, to investigate whether CSF p-tau biomarkers and [18F]flortaucipir PET provide complementary information regarding disease severity, we investigated associations of both CSF p-tau and [18F]flortaucipir PET with multiple cognitive domains and regional atrophy.